Literature DB >> 21635609

Electrocardiographic versus echocardiographic optimization of the interventricular pacing delay in patients undergoing cardiac resynchronization therapy.

David Tamborero1, Barbara Vidal, Jose Maria Tolosana, Marta Sitges, Antonio Berruezo, Etelvino Silva, Mángeles Castel, Mariona Matas, Elena Arbelo, Jose Rios, Julián Villacastín, Josep Brugada, Lluís Mont.   

Abstract

INTRODUCTION: Echocardiographic optimization of the VV interval may improve CRT response, but it is time-consuming and not routinely performed. The aim of this study was to compare the response to cardiac resynchronization therapy (CRT) when the interventricular pacing (VV) interval was optimized by tissue Doppler imaging (TDI) to CRT response when it was optimized following QRS width criteria. METHODS AND
RESULTS: The study included 156 consecutive CRT patients with severe heart failure and left bundle-branch block configuration. Atrioventricular interval was selected according to a pulsed Doppler assessment, and VV optimization was randomly assigned to echocardiography (ECHO group, n = 78) or electrocardiography (ECG group, n = 78). Optimal VV was defined for the ECHO group as producing the best LV intraventricular synchrony according to TDI displacement curves and for the ECG group as resulting in the narrowest QRS measured from the earliest deflection. At 6-month follow-up, percentage of echocardiographic responders (defined as neither death nor heart transplantation and a LV end-systolic volume reduction >10%) was higher in the ECG optimized group (50.0% vs 67.9%; P = 0.023), whereas clinical response (defined as neither death nor heart transplantation and >10% improvement in the 6-minute walking test) was similar in both groups (71.8% vs 73.1%; P = 0.858).
CONCLUSIONS: VV optimization based on QRS width obtained a higher percentage of responders in terms of LV reverse remodeling compared to the TDI method.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21635609     DOI: 10.1111/j.1540-8167.2011.02085.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  6 in total

Review 1.  Resynchronization Therapy for Patients with Congenital Heart Disease: Are We Ready for Prime Time?

Authors:  Scott Anjewierden; Peter F Aziz
Journal:  Curr Cardiol Rep       Date:  2018-07-18       Impact factor: 2.931

2.  Determinants of Response to Cardiac Resynchronization Therapy.

Authors:  John D Allison; Yitschak Biton; Theofanie Mela
Journal:  J Innov Card Rhythm Manag       Date:  2022-05-15

3.  Vectorcardiography for optimization of stimulation intervals in cardiac resynchronization therapy.

Authors:  Caroline J M van Deursen; Liliane Wecke; Wouter M van Everdingen; Marcus Ståhlberg; Michel H G Janssen; Frieder Braunschweig; Lennart Bergfeldt; Harry J G M Crijns; Kevin Vernooy; Frits W Prinzen
Journal:  J Cardiovasc Transl Res       Date:  2015-03-06       Impact factor: 4.132

4.  Programming Cardiac Resynchronization Therapy for Electrical Synchrony: Reaching Beyond Left Bundle Branch Block and Left Ventricular Activation Delay.

Authors:  Niraj Varma; David O'Donnell; Mohammed Bassiouny; Philippe Ritter; Carlo Pappone; Jan Mangual; Daniel Cantillon; Nima Badie; Bernard Thibault; Brian Wisnoskey
Journal:  J Am Heart Assoc       Date:  2018-02-06       Impact factor: 5.501

5.  Electrically guided versus imaging-guided implant of the left ventricular lead in cardiac resynchronization therapy: a study protocol for a double-blinded randomized controlled clinical trial (ElectroCRT).

Authors:  Charlotte Stephansen; Anders Sommer; Mads Brix Kronborg; Jesper Møller Jensen; Kirsten Bouchelouche; Jens Cosedis Nielsen
Journal:  Trials       Date:  2018-11-01       Impact factor: 2.279

6.  Optimization of Chronic Cardiac Resynchronization Therapy Using Fusion Pacing Algorithm Improves Echocardiographic Response.

Authors:  Ahmed AlTurki; Pedro Y Lima; Martin L Bernier; Daniel Garcia; Alejandro Vidal; Bruno Toscani; Sergio Diaz; Mauricio Montemezzo; Alaa Al-Dossari; Tomy Hadjis; Jacqueline Joza; Vidal Essebag
Journal:  CJC Open       Date:  2020-01-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.